| The Development of a Biotinylated NAD(+)-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay | |
| Ji, Ming; Wang, Liyuan; Xue, Nina; Lai, Fangfang; Zhang, Sen; Jin, Jing; Chen, Xiaoguang | |
| 2018 | |
| 卷号 | 23期号:6页码:545-553 |
| 关键词 | PARP3 PARP1/2 inhibitor biotinylated NAD(+) ELISA |
| ISSN号 | 2472-5552 |
| DOI | 10.1177/2472555218767843 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6360384 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Ji, Ming,Wang, Liyuan,Xue, Nina,et al. The Development of a Biotinylated NAD(+)-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay[J],2018,23(6):545-553. |
| APA | Ji, Ming.,Wang, Liyuan.,Xue, Nina.,Lai, Fangfang.,Zhang, Sen.,...&Chen, Xiaoguang.(2018).The Development of a Biotinylated NAD(+)-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay.,23(6),545-553. |
| MLA | Ji, Ming,et al."The Development of a Biotinylated NAD(+)-Applied Human Poly(ADP-Ribose) Polymerase 3 (PARP3) Enzymatic Assay".23.6(2018):545-553. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论